ARTA
DMK

A.R.T. Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

A.R.T. Advisors’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-292
Closed -$16K – 121
2020
Q3 		$16K Buy
+292
New +$17.3K 0.09% 64
2019
Q4 		– Sell
-616
Closed -$30K – 1810
2019
Q3 		$30K Sell
616
-266
-30% -$19.1K ﹤0.01% 1353
2019
Q2 		$80K Buy
882
+520
+144% +$63.2K ﹤0.01% 1221
2019
Q1 		$53K Buy
+362
New +$70K ﹤0.01% 1212
2016
Q3 		– Sell
-441
Closed -$86K – 1246
2016
Q2 		$86K Buy
+441
New +$203K ﹤0.01% 1221

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

A.R.T. Advisors's DMK Position: Q4 2020 in Review

A.R.T. Advisors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2020, closing a stake of 292 shares — an estimated $16K sold.

A.R.T. Advisors first reported a position in DMK in Q2 2016 and held it in 5 quarters. The position peaked at $86K in Q2 2016. 41 funds tracked by Wall St. Rank hold DMK as of Q4 2020.

  • A.R.T. Advisors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 292 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2020, an estimated $16K.
  • A.R.T. Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2016 and held it in 5 quarters.
  • A.R.T. Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $86K in Q2 2016.
  • 41 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2020.

Based on A.R.T. Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.